metoclopramide has been researched along with Adenoma in 47 studies
Metoclopramide: A dopamine D2 antagonist that is used as an antiemetic.
metoclopramide : A member of the class of benzamides resulting from the formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with the primary amino group of N,N-diethylethane-1,2-diamine.
Adenoma: A benign epithelial tumor with a glandular organization.
| Excerpt | Relevance | Reference |
|---|---|---|
| " In this study, we compared the results of noninvasive tests including (1) assay of urinary catecholamines and their metabolites, (2) a provocative pharmacologic test using metoclopramide (MCP test), and (3) 131I-metaiodobenzylguanidine (MIBG) scintigraphy to screen for pheochromocytoma in 10 consecutive patients with an incidentally discovered adrenal mass (6 pheochromocytomas and 4 non-functioning adrenocortical adenomas)." | 9.09 | [Noninvasive screening for pheochromocytoma in patients with an incidentally discovered adrenal mass: usefulness of provocative test with metoclopramide and 131I-metaiodobenzylguanidine scintigraphy]. ( Tsuji, Y; Yokoyama, H, 1999) |
| "The ergoline derivative, Metergoline, in a dosage of 4 to 24 mg/day, was administered for one to eight months to 42 patients with hyperprolactinemic amenorrhea." | 7.67 | Treatment of hyperprolactinemic amenorrhea with Metergoline. ( Bohnet, HG; Kato, K; Wolf, AS, 1986) |
| " We have compared the TSH and PRL responses to metoclopramide (MCP) in normal and postpartum lactating women with those in 28 patients with hyperprolactinemia of different origin." | 7.67 | Evaluation of dopaminergic tone in hyperprolactinemia. III. Thyroid-stimulating hormone response to metoclopramide in differential diagnosis and postoperative follow-up of prolactinoma patients. ( Anile, C; Barbarino, A; De Marinis, L; Maira, G; Mancini, A; Masala, R; Minnielli, S, 1985) |
| "Plasma mineralocorticoid and prolactin levels were evaluated before and 15, 30, 60 and 120 min after the administration of 10 mg metoclopramide in seven normotensive volunteers (42 +/- 5 (SD) years), as well as in ten patients with primary aldosteronism five with aldosterone-producing adenoma (49 +/- 4), and five with bilateral hyperplasia (47 +/- 3)." | 7.66 | Mineralocorticoid and prolactin response to the dopamine antagonist metoclopramide in patients with primary aldosteronism. ( von Werder, K; Weber, PC; Witzgall, H, 1983) |
| "The degree of autonomy in prolactin secreting pituitary adenomas and also prolactin secretory reserve in cases with suspected functional galactorrhea syndrome was evaluated with the use of metoclopramide, TRH and L-DOPA." | 7.66 | The effect of metoclopramide, TRH and L-dopa on prolactin secretion in pituitary adenoma and in "functional" galactorrhoea syndrome. ( Jeske, W, 1979) |
| "A patient with a rare combination of prolactinoma and aldosterone producing adrenal adenoma (APA) was reported in relation to studies concerning dopaminergic regulation of PRL and aldosterone secretion." | 5.28 | A patient with a prolactinoma associated with an aldosterone producing adrenal adenoma: differences in dopaminergic regulation of PRL and aldosterone secretion. ( Demura, H; Demura, R; Isawa, M; Naruse, K; Naruse, M; Onoda, N; Yamakado, M, 1992) |
| " In this study, we compared the results of noninvasive tests including (1) assay of urinary catecholamines and their metabolites, (2) a provocative pharmacologic test using metoclopramide (MCP test), and (3) 131I-metaiodobenzylguanidine (MIBG) scintigraphy to screen for pheochromocytoma in 10 consecutive patients with an incidentally discovered adrenal mass (6 pheochromocytomas and 4 non-functioning adrenocortical adenomas)." | 5.09 | [Noninvasive screening for pheochromocytoma in patients with an incidentally discovered adrenal mass: usefulness of provocative test with metoclopramide and 131I-metaiodobenzylguanidine scintigraphy]. ( Tsuji, Y; Yokoyama, H, 1999) |
| "To investigate the possible role of dopamine, a catecholamine with natriuretic properties, in modulating the escape from the sodium-retaining effects of mineralocorticoids, we submitted six aldosterone-producing adenoma (APA) patients and six low-renin essential hypertensive patients to acute volume expansion by head-out water immersion with or without dopaminergic blockade by metoclopramide." | 3.69 | Escape from the sodium-retaining effects of mineralocorticoids: is there a role for dopamine? ( Coruzzi, P, 1994) |
| "In 24 patients who had a PRL-secreting pituitary adenoma, diagnosed by pituitary dynamic function tests and CT scan, and confirmed at surgery, the TSH response to a dopamine (DA)-antagonist drug, metoclopramide (MCP), was studied pre- and postoperatively to elucidate whether altered DA tone was present and related to hyperprolactinemia." | 3.67 | Postoperative evaluation of dopaminergic tone in prolactinoma patients. II. Plasma thyrotropin response to metoclopramide. ( Anile, C; Barbarino, A; De Marinis, L; Maira, G; Mancini, A; Menini, E, 1984) |
| " Furthermore, to evaluate whether high circulating PRL levels influence the activity of the opioid system after the menopause, a group of seven postmenopausal subjects was tested before and 1 week after the administration of metoclopramide (10 mg, three times a day), a dopamine receptor antagonist." | 3.67 | Differences in the opioid control of luteinizing hormone secretion between pathological and iatrogenic hyperprolactinemic states. ( Brambilla, F; De Leo, V; Facchinetti, F; Genazzani, AR; Montemagno, U; Nappi, C; Petraglia, F, 1987) |
| " The pharyngeal hypophysis from a patient with primary hypothyroidism was hypertrophic, with TSH cell hyperplasia; while that from a patient treated with metoclopramide, a dopamine-receptor-blocking drug, showed PRL cell hyperplasia." | 3.67 | Immunocytochemical evidence for the ability of the human pharyngeal hypophysis to respond to change in endocrine feedback. ( Ciocca, DR; Puy, LA; Stati, AO, 1985) |
| "The ergoline derivative, Metergoline, in a dosage of 4 to 24 mg/day, was administered for one to eight months to 42 patients with hyperprolactinemic amenorrhea." | 3.67 | Treatment of hyperprolactinemic amenorrhea with Metergoline. ( Bohnet, HG; Kato, K; Wolf, AS, 1986) |
| "In order to determine whether endogenous dopaminergic tone has any role in the diurnal variation in TSH secretion, the 24-h secretory pattern of TSH and the TSH response to a dopamine antagonist, metoclopramide (MCP), were evaluated in normal women (n = 4) and in hyperprolactinemic-amenorrheic women with pituitary microadenoma (n = 6)." | 3.67 | Twenty-four hour secretory pattern of thyroid-stimulating hormone in hyperprolactinemic women with pituitary microadenoma. ( Kato, K; Seki, K; Shima, K; Uesato, T, 1985) |
| " We have compared the TSH and PRL responses to metoclopramide (MCP) in normal and postpartum lactating women with those in 28 patients with hyperprolactinemia of different origin." | 3.67 | Evaluation of dopaminergic tone in hyperprolactinemia. III. Thyroid-stimulating hormone response to metoclopramide in differential diagnosis and postoperative follow-up of prolactinoma patients. ( Anile, C; Barbarino, A; De Marinis, L; Maira, G; Mancini, A; Masala, R; Minnielli, S, 1985) |
| "The sexual behavior, hypothalamic-pituitary-testicular axis and seminal fluid parameters in three different models of hyperprolactinaemia were studied: patients with prolactin secreting pituitary adenomas, normal volunteers before and during metoclopramide, and psychotic patients on chronic neuroleptic therapy." | 3.66 | Reproductive parameters in prolactinaemic men. ( D'Urso, R; Falaschi, P; Frajese, G; Pompei, P; Rocco, A, 1983) |
| "Plasma mineralocorticoid and prolactin levels were evaluated before and 15, 30, 60 and 120 min after the administration of 10 mg metoclopramide in seven normotensive volunteers (42 +/- 5 (SD) years), as well as in ten patients with primary aldosteronism five with aldosterone-producing adenoma (49 +/- 4), and five with bilateral hyperplasia (47 +/- 3)." | 3.66 | Mineralocorticoid and prolactin response to the dopamine antagonist metoclopramide in patients with primary aldosteronism. ( von Werder, K; Weber, PC; Witzgall, H, 1983) |
| " The diagnosis of prolactinoma was made in three of the 16 patients by the absence of PRL response to thyrotropin-releasing factor (TRF) and a dopamine receptor antagonist, metoclopramide, without radiologic evidence of an adenoma." | 3.66 | Changes in pituitary hormones during and following transsphenoidal removal of prolactinomas. ( Alksne, J; Casper, RF; Gilliland, B; Quigley, ME; Rakoff, JS; Yen, SS, 1980) |
| "The administration of a dopamine-receptor antagonist, metoclopramide (10 mg, intravenous bolus), elicited a significant increase in the circulating concentration of thyroid-stimulating hormone (TSH) which was substantially greater for hyperprolactinemic patients with pituitary microadenoma than for normal women during the early follicular phase of the cycle." | 3.66 | Evidence for increased dopaminergic inhibition of secretion of thyroid-stimulating hormone in hyperprolactinemic patients with pituitary microadenoma. ( Quigley, ME; Yen, SS, 1980) |
| "The degree of autonomy in prolactin secreting pituitary adenomas and also prolactin secretory reserve in cases with suspected functional galactorrhea syndrome was evaluated with the use of metoclopramide, TRH and L-DOPA." | 3.66 | The effect of metoclopramide, TRH and L-dopa on prolactin secretion in pituitary adenoma and in "functional" galactorrhoea syndrome. ( Jeske, W, 1979) |
| "Administration of a dopamine (DA) antagonist, metoclopramide (MCP) resulted in dose-related acute increments of circulating levels of LH and FSH in patients with hyperprolactinemic anovulation due to pituitary microadenoma but not in normal cycling women during the early follicular phase." | 3.66 | Effects of a dopamine antagonist on the release of gonadotropin and prolactin in normal women and women with hyperprolactinemic anovulation. ( Gilliland, GB; Judd, SJ; Quigley, ME; Yen, SS, 1979) |
| "A patient with a rare combination of prolactinoma and aldosterone producing adrenal adenoma (APA) was reported in relation to studies concerning dopaminergic regulation of PRL and aldosterone secretion." | 1.28 | A patient with a prolactinoma associated with an aldosterone producing adrenal adenoma: differences in dopaminergic regulation of PRL and aldosterone secretion. ( Demura, H; Demura, R; Isawa, M; Naruse, K; Naruse, M; Onoda, N; Yamakado, M, 1992) |
| "Metergoline pretreatment significantly reduced the aldosterone response to metoclopramide, together with a slight reduction of prolactin, whereas no changes were seen on PRA, cortisol and K." | 1.27 | Effect of metergoline on the aldosterone-stimulating properties of metoclopramide. ( Boscaro, M; D'Agostino, D; Fallo, F; Mantero, F; Murgia, A; Opocher, G, 1983) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 39 (82.98) | 18.7374 |
| 1990's | 7 (14.89) | 18.2507 |
| 2000's | 1 (2.13) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Teasdale, GM | 1 |
| Ratcliffe, JG | 1 |
| Thomson, JA | 1 |
| Cowden, EA | 1 |
| Rocco, A | 2 |
| Falaschi, P | 2 |
| Pompei, P | 1 |
| D'Urso, R | 2 |
| Frajese, G | 2 |
| Opocher, G | 1 |
| Murgia, A | 1 |
| Boscaro, M | 1 |
| D'Agostino, D | 1 |
| Fallo, F | 1 |
| Mantero, F | 1 |
| Teasdale, G | 1 |
| Seki, K | 3 |
| Uesato, T | 2 |
| Kato, K | 5 |
| Shima, K | 3 |
| Witzgall, H | 2 |
| von Werder, K | 1 |
| Weber, PC | 2 |
| De Marinis, L | 7 |
| Mancini, A | 3 |
| Maira, G | 7 |
| Anile, C | 7 |
| Menini, E | 5 |
| Barbarino, A | 7 |
| Casper, RF | 1 |
| Rakoff, JS | 1 |
| Quigley, ME | 4 |
| Gilliland, B | 1 |
| Alksne, J | 1 |
| Yen, SS | 4 |
| Tucker, HS | 1 |
| Grubb, SR | 1 |
| Wigand, JP | 1 |
| Taylon, A | 1 |
| Lankford, HV | 1 |
| Blackard, WG | 1 |
| Becker, DP | 1 |
| De Giorgio, G | 1 |
| Toffano, G | 1 |
| Merlini, G | 1 |
| Müller, OA | 1 |
| De Gennes, JL | 1 |
| Turpin, G | 1 |
| Heshmati, HM | 1 |
| Carayon, A | 1 |
| Gasparoni, P | 1 |
| Fioretti, D | 1 |
| Roncato, F | 1 |
| Rota, G | 1 |
| Conte, N | 1 |
| Cooper, BT | 1 |
| Mountford, RA | 1 |
| McKee, C | 1 |
| Andersen, AN | 1 |
| Tabor, A | 1 |
| Judd, SJ | 2 |
| Gilliland, GB | 2 |
| Gonzalez-Villapando, C | 1 |
| Szabo, M | 1 |
| Frohman, LA | 1 |
| Wu, KD | 2 |
| Chen, YM | 2 |
| Chu, JS | 1 |
| Hung, KY | 1 |
| Hsieh, TS | 1 |
| Hsieh, BS | 2 |
| Coruzzi, P | 1 |
| Naruse, M | 2 |
| Naruse, K | 2 |
| Yoshimoto, T | 1 |
| Tanaka, M | 1 |
| Tanabe, A | 1 |
| Imaki, T | 1 |
| Shibasaki, T | 1 |
| Demura, R | 2 |
| Demura, H | 2 |
| Yokoyama, H | 1 |
| Tsuji, Y | 1 |
| Liao, TS | 1 |
| Lai, MK | 1 |
| Chen, SJ | 1 |
| Su, CT | 1 |
| Chu, TS | 1 |
| Chang, CC | 1 |
| Jeske, W | 1 |
| Pineda, G | 1 |
| Valdes, M | 1 |
| Castro, M | 1 |
| Stevenson, C | 1 |
| Bohnet, HG | 2 |
| Hanker, JP | 1 |
| Horowski, R | 1 |
| Wickings, EJ | 1 |
| Schneider, HP | 1 |
| Isawa, M | 1 |
| Onoda, N | 1 |
| Yamakado, M | 1 |
| Magner, JA | 1 |
| Kane, J | 1 |
| Gerasimov, G | 1 |
| Chernova, T | 1 |
| Goncharov, N | 1 |
| Chen, CF | 1 |
| Kurachi, H | 1 |
| Miyake, A | 1 |
| Aono, T | 1 |
| Tanizawa, O | 1 |
| Petraglia, F | 1 |
| De Leo, V | 1 |
| Nappi, C | 1 |
| Facchinetti, F | 1 |
| Montemagno, U | 1 |
| Brambilla, F | 1 |
| Genazzani, AR | 1 |
| Gláz, E | 1 |
| Rácz, K | 1 |
| Varga, I | 1 |
| Kiss, R | 1 |
| Sergev, O | 1 |
| Fútó, L | 1 |
| Szécsény, A | 1 |
| Schaff, Z | 1 |
| McLellan, AR | 1 |
| Connell, JM | 1 |
| Alexander, WD | 1 |
| Davies, DL | 1 |
| Serri, O | 1 |
| Beauregard, H | 1 |
| Somma, M | 1 |
| Comtois, R | 1 |
| Jilwan, N | 1 |
| Hardy, J | 1 |
| Ciocca, DR | 1 |
| Puy, LA | 1 |
| Stati, AO | 1 |
| Ho, KY | 1 |
| Smythe, GA | 1 |
| Compton, PJ | 1 |
| Lazarus, L | 1 |
| D'Amico, C | 1 |
| Passeri, M | 1 |
| Sambo, P | 1 |
| Wolf, AS | 1 |
| Minnielli, S | 1 |
| Masala, R | 1 |
| Yanase, T | 1 |
| Nawata, H | 1 |
| Higuchi, K | 1 |
| Ibayashi, H | 1 |
1 review available for metoclopramide and Adenoma
| Article | Year |
|---|---|
Surgical management of pituitary adenoma.
Topics: Acromegaly; Adenoma; Cushing Syndrome; Female; Humans; Metoclopramide; Pituitary Gland; Pituitary Ne | 1983 |
2 trials available for metoclopramide and Adenoma
| Article | Year |
|---|---|
Dopaminergic regulation of aldosterone secretion: its pathophysiologic significance in subsets of primary aldosteronism.
Topics: Adenoma; Adrenal Gland Neoplasms; Adult; Aged; Aldosterone; Dopamine; Dopamine Antagonists; Female; | 1995 |
[Noninvasive screening for pheochromocytoma in patients with an incidentally discovered adrenal mass: usefulness of provocative test with metoclopramide and 131I-metaiodobenzylguanidine scintigraphy].
Topics: 3-Iodobenzylguanidine; Adenoma; Adrenal Gland Neoplasms; Adult; Biomarkers; Catecholamines; Diagnosi | 1999 |
44 other studies available for metoclopramide and Adenoma
| Article | Year |
|---|---|
The prolactinoma problem.
Topics: Adenoma; Female; Hormones; Humans; Metoclopramide; Pituitary Function Tests; Pituitary Neoplasms; Pr | 1980 |
Reproductive parameters in prolactinaemic men.
Topics: Adenoma; Antipsychotic Agents; Bromocriptine; Erectile Dysfunction; Humans; Male; Metoclopramide; Pi | 1983 |
Effect of metergoline on the aldosterone-stimulating properties of metoclopramide.
Topics: Adenoma; Adrenal Gland Neoplasms; Adult; Aldosterone; Ergolines; Female; Humans; Hydrocortisone; Kin | 1983 |
Functional evaluation of the adenohypophysis with metoclopramide in hyperprolactinemic-amenorrheic women in relation to radiological findings on the sella turcica.
Topics: Adenoma; Adult; Amenorrhea; Female; Humans; Luteinizing Hormone; Metoclopramide; Pituitary Gland, An | 1984 |
Mineralocorticoid and prolactin response to the dopamine antagonist metoclopramide in patients with primary aldosteronism.
Topics: Adenoma; Adult; Female; Humans; Hyperaldosteronism; Kinetics; Male; Metoclopramide; Middle Aged; Min | 1983 |
Postoperative evaluation of dopaminergic tone in prolactinoma patients. II. Plasma thyrotropin response to metoclopramide.
Topics: Adenoma; Adolescent; Adult; Dopamine; Female; Humans; Metoclopramide; Pituitary Function Tests; Pitu | 1984 |
Changes in pituitary hormones during and following transsphenoidal removal of prolactinomas.
Topics: Adenoma; Adult; Female; Follicle Stimulating Hormone; Follow-Up Studies; Growth Hormone; Humans; Lut | 1980 |
Normal pituitary function and reserve after selective transsphenoidal removal of a thyrotropin-producing pituitary adenoma.
Topics: Adenoma; Adult; Bromocriptine; Female; Humans; Levodopa; Metoclopramide; Microsurgery; Pituitary Gla | 1980 |
Galactorrhea-amenorrhea syndrome: follow-up of forty-five patients after pituitary tumor removal.
Topics: Adenoma; Adult; Amenorrhea; Chlorpromazine; Female; Follow-Up Studies; Galactorrhea; Humans; Lactati | 1981 |
[Clinical and experimental studies of the mechanism of neuroendocrine action of cerebral phospholipids: the behavior of prolactin as a marker of such action].
Topics: Adenoma; Adult; Female; Humans; Liposomes; Male; Metoclopramide; Middle Aged; Phospholipids; Pituita | 1981 |
Dopaminergic mechanisms regulating prolactin secretion in patients with prolactin-secreting pituitary adenoma. Long-term studies after selective transsphenoidal surgery.
Topics: Adenoma; Adolescent; Adult; Carbidopa; Dopamine; Female; Follow-Up Studies; Humans; Levodopa; Metocl | 1982 |
Clinical and biochemical features of patients with aldosterone-producing adenoma and idiopathic hyperaldosteronism.
Topics: 18-Hydroxycorticosterone; 18-Hydroxydesoxycorticosterone; Adenoma; Adrenal Cortex Neoplasms; Adult; | 1983 |
[Progress in the hormonal detection of pituitary prolactin adenoma].
Topics: Adenoma; Bromocriptine; Domperidone; Humans; Metoclopramide; Nomifensine; Pituitary Neoplasms; Prola | 1982 |
[Effect of bromopride on prolactin secretion].
Topics: Adenoma; Adolescent; Adult; Female; Humans; Male; Metoclopramide; Middle Aged; Pituitary Gland; Pitu | 1982 |
Galactorrhoea, hyperprolactinaemia, and pituitary adenoma presenting during metoclopramide therapy.
Topics: Adenoma; Female; Galactorrhea; Humans; Lactation Disorders; Metoclopramide; Middle Aged; Pituitary N | 1982 |
Prl, TSH, GH and LH responses to metoclopramide and breast-feeding in normal and hyperprolactinaemic women.
Topics: Adenoma; Adult; Breast Feeding; Female; Growth Hormone; Humans; Lactation; Luteinizing Hormone; Meto | 1982 |
Functional studies of dopamine control of prolactin secretion in normal women and women with hyperprolactinemic pituitary microadenoma.
Topics: Adenoma; Adult; Dopamine; Female; Follicular Phase; Humans; Kinetics; Metoclopramide; Pituitary Neop | 1980 |
Evidence for increased dopaminergic inhibition of secretion of thyroid-stimulating hormone in hyperprolactinemic patients with pituitary microadenoma.
Topics: Adenoma; Adult; Dopamine; Female; Humans; Hypothalamus; Menstruation; Metoclopramide; Pituitary Neop | 1980 |
Central nervous system-mediated stimulation of prolactin secretion by cimetidine, a histamine H2-receptor antagonist: impaired responsiveness in patients with prolactin-secreting tumors and idiopathic hyperprolactinemia.
Topics: Adenoma; Adolescent; Adult; Animals; Carbidopa; Cimetidine; Female; Guanidines; Humans; Levodopa; Ma | 1980 |
Zona fasciculata-like cells determine the response of plasma aldosterone to metoclopramide and aldosterone synthase messenger ribonucleic acid level in aldosterone-producing adenoma.
Topics: Adenoma; Adrenal Gland Neoplasms; Aldosterone; Base Sequence; Cytochrome P-450 CYP11B2; Cytochrome P | 1995 |
Escape from the sodium-retaining effects of mineralocorticoids: is there a role for dopamine?
Topics: Adenoma; Adult; Aldosterone; Atrial Natriuretic Factor; Blood Pressure; Creatinine; Dopamine; Female | 1994 |
Preoperative diagnosis and localization of aldosterone-producing adenoma by adrenal venous sampling after administration of metoclopramide.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Adrenocorticotropic Hormone; Adult; Aged; Aldoster | 2001 |
The effect of metoclopramide, TRH and L-dopa on prolactin secretion in pituitary adenoma and in "functional" galactorrhoea syndrome.
Topics: Acromegaly; Adenoma; Adult; Amenorrhea; Female; Galactorrhea; Humans; Lactation Disorders; Levodopa; | 1979 |
Prolactin-secreting pituitary adenomas: prolactin dynamics before and after transsphenoidal surgery.
Topics: Adenoma; Adolescent; Adult; Bromocriptine; Female; Humans; Hypothalamus; Metergoline; Metoclopramide | 1979 |
Pituitary microadenoma: diagnostic studies.
Topics: Adenoma; Adolescent; Adult; Bromocriptine; Female; Humans; Metoclopramide; Pituitary Function Tests; | 1979 |
Serum prolactin response to thyrotropin-releasing hormone and metoclopramide in patients with prolactin-secreting tumors before and after transsphenoidal surgery.
Topics: Adenoma; Adolescent; Adult; Female; Humans; Lactation; Metoclopramide; Pituitary Neoplasms; Pregnanc | 1978 |
Suppression of prolactin secretion by lisuride throughout the menstrual cycle and in hyperprolactinaemic menstrual disorders.
Topics: Adenoma; Administration, Oral; Adult; Ergolines; Estradiol; Female; Follicle Stimulating Hormone; Go | 1979 |
Effects of a dopamine antagonist on the release of gonadotropin and prolactin in normal women and women with hyperprolactinemic anovulation.
Topics: Adenoma; Adult; Amenorrhea; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Menst | 1979 |
A patient with a prolactinoma associated with an aldosterone producing adrenal adenoma: differences in dopaminergic regulation of PRL and aldosterone secretion.
Topics: Adenoma; Adrenal Gland Neoplasms; Adult; Aldosterone; Bromocriptine; Dopamine; Female; Humans; Metoc | 1992 |
Binding of thyrotropin to lentil lectin is unchanged by thyrotropin-releasing hormone administration in three patients with thyrotropin-producing pituitary adenomas.
Topics: Adenoma; Adult; Chromatography, Affinity; Female; Humans; Hyperthyroidism; Immunoradiometric Assay; | 1992 |
Monoamine regulation of prolactin and TSH secretion in hypothyroidism.
Topics: Adenoma; Adult; Cyproheptadine; Dopamine; Female; Humans; Hyperprolactinemia; Hypothyroidism; Metocl | 1992 |
Suppression of serum immunoreactive human epidermal growth factor by acute increase in prolactin in women.
Topics: Adenoma; Adolescent; Adult; Epidermal Growth Factor; Female; Humans; Hyperprolactinemia; Metoclopram | 1989 |
Differences in the opioid control of luteinizing hormone secretion between pathological and iatrogenic hyperprolactinemic states.
Topics: Adenoma; Adult; Amenorrhea; Antipsychotic Agents; Dopamine Antagonists; Endorphins; Female; Humans; | 1987 |
Atrial natriuretic peptide directly inhibits corticosteroid biosynthesis in human aldosterone-producing adenoma.
Topics: Adenoma; Adrenal Cortex Hormones; Adrenal Gland Neoplasms; Aldosterone; Atrial Natriuretic Factor; C | 1988 |
Clinical response of thyrotropin-secreting macroadenoma to bromocriptine and radiotherapy.
Topics: Adenoma; Bromocriptine; Dexamethasone; Humans; Iodine Radioisotopes; Male; Metoclopramide; Middle Ag | 1988 |
Defective dopaminergic regulation of prolactin secretion in patients with hyperprolactinemia.
Topics: Adenoma; Adult; Dopamine; Female; Humans; Hyperprolactinemia; Metoclopramide; Middle Aged; Pituitary | 1988 |
Parallelism in the luteinizing hormone responses to opioid and dopamine antagonists in hyperprolactinemic women with pituitary microadenoma.
Topics: Adenoma; Adult; Dopamine Antagonists; Female; Humans; Hyperprolactinemia; Luteinizing Hormone; Metoc | 1986 |
Immunocytochemical evidence for the ability of the human pharyngeal hypophysis to respond to change in endocrine feedback.
Topics: Adenoma; Adolescent; Aged; Bronchial Diseases; Endocrine Glands; Feedback; Female; Histocytochemistr | 1985 |
Long-term bromocriptine therapy may restore the inhibitory control of prolactin release in some patients with pathological hyperprolactinemia.
Topics: Adenoma; Adolescent; Adult; Bromocriptine; Female; Humans; Male; Metoclopramide; Middle Aged; Pituit | 1985 |
Prolactin dynamics in patients with non-secretin tumours of the hypothalamic-pituitary region.
Topics: Adenoma; Adenoma, Chromophobe; Adolescent; Adult; Craniopharyngioma; Female; Follicle Stimulating Ho | 1985 |
Treatment of hyperprolactinemic amenorrhea with Metergoline.
Topics: Adenoma; Adult; Amenorrhea; Ergolines; Female; Humans; Hyperprolactinemia; Metergoline; Metocloprami | 1986 |
Twenty-four hour secretory pattern of thyroid-stimulating hormone in hyperprolactinemic women with pituitary microadenoma.
Topics: Adenoma; Adult; Circadian Rhythm; Female; Humans; Hyperprolactinemia; Metoclopramide; Pituitary Glan | 1985 |
Evaluation of dopaminergic tone in hyperprolactinemia. III. Thyroid-stimulating hormone response to metoclopramide in differential diagnosis and postoperative follow-up of prolactinoma patients.
Topics: Adenoma; Adolescent; Adult; Diagnosis, Differential; Empty Sella Syndrome; Female; Humans; Hyperprol | 1985 |
[The effects of metoclopramide and dopamine on aldosterone secretion in cultured adrenocortical adenoma cells and adjacent non-adenoma cells from patients with primary aldosteronism].
Topics: Adenoma; Adrenal Cortex; Adrenal Cortex Neoplasms; Adult; Aldosterone; Cells, Cultured; Chromatograp | 1985 |